Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India (Q47996539)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 November 2011

Language	Label	Description	Also known as
English	Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India	scientific article published on 28 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

1 reference

based on heuristic

inferred from title

author name string

Sonia D Lourembam

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

Shashi Baruah

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

language of work or name

0 references

publication date

28 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

30

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

767-773

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

A polymerase chain reaction/ligase detection reaction fluorescent microsphere assay to determine Plasmodium falciparum MSP-119 haplotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Antigenic diversity and immune evasion by malaria parasites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Treatment-seeking for febrile illness in north-east India: an epidemiological study in the malaria endemic zone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Temporal and spatial variation in MSP1 clonal composition of Plasmodium falciparum in districts of Assam, Northeast India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Physiographic and entomologic risk factors of malaria in Assam, India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Genomic inferences on peopling of south Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Different antibody- and cytokine-mediated responses to Plasmodium falciparum parasite in two sympatric ethnic tribes living in Mali

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Genome-wide linkage analysis of malaria infection intensity and mild disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese vi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

The profile of IgG-antibody response against merozoite surface proteins 1 and 2 in severe Plasmodium falciparum malaria in Eastern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

based on heuristic

inferred from DOI database lookup

Short report: IgG1/IgG3 antibody responses to various analogs of recombinant ypfmsp119--a study in immune adults living in areas of Plasmodium falciparum transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.11.069

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22133506

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47996539&oldid=2180972904"